Form 4: DENTSPLY SIRONA CEO Scavilla Boosts RSU Holdings
Insider Transaction Report
DENTSPLY SIRONA Inc. CEO Daniel T. Scavilla acquired 223.681 additional restricted stock units as dividend equivalents, increasing his direct beneficial ownership to 17,698.73 shares.
Summary
- Daniel T. Scavilla, President, CEO, and Director of DENTSPLY SIRONA Inc. (XRAY), reported an acquisition of common stock.
- On October 10, 2025, Scavilla acquired 223.681 shares of common stock at a price of $0 per share.
- These shares represent dividends on previously awarded restricted stock units (RSUs), issued in the form of additional RSUs.
- The newly acquired RSUs are subject to the same vesting terms as the underlying awards and vest simultaneously.
- Each RSU converts to common stock on a 1:1 basis.
- Following this transaction, Scavilla directly beneficially owns 17,698.73 shares of DENTSPLY SIRONA Inc. common stock.
- The transaction was made pursuant to a Rule 10b5-1(c) plan.
Sentiment
Score: 7
Explanation: The filing indicates an increase in executive ownership through RSU dividend equivalents, which generally aligns management interests with shareholders. This is a routine compensation event.
Positives
- Increase in executive's beneficial ownership, aligning management interests with shareholders.
- Acquisition of shares through dividend equivalents on RSUs indicates an ongoing and structured executive compensation program.
Negatives
- No direct cash investment by the executive, as shares were acquired at a $0 price as part of compensation.
Future Outlook
NA
Industry Context
NA
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Insider Trading Plan | Transaction executed under a Rule 10b5-1(c) plan, providing an affirmative defense against insider trading allegations. | 10/10/2025 | Enhances transparency and compliance regarding executive stock transactions. |
Stakeholder Impact
- Shareholders: Increased alignment with management due to higher executive ownership.
Key Dates
| Date | Description |
|---|---|
| 10/10/2025 | Date of earliest transaction (acquisition of RSU dividend equivalents) |
| 10/15/2025 | Date Form 4 was signed and filed |
Recommendation
holdThis Form 4 reports a routine acquisition of shares by the CEO as part of his compensation package (RSU dividend equivalents). While it increases executive ownership and aligns interests, it does not provide new fundamental information to warrant a change in investment recommendation based solely on this filing.
Keywords
DENTSPLY SIRONA, XRAY, Daniel T. Scavilla, Form 4, insider transaction, RSU, restricted stock units, dividend equivalents, executive compensation, beneficial ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.